Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
Pre-NOC submission guidelines – Pilot project
-
Happy Friday @manufacturer and @agency
PAAB is excited to announce that as of December 1st, we will be piloting an expanded approach to pre-NOC review practices that will allow for more pieces to be submitted pre-NOC and prior to the final draft stage of the PM.
Learn more here and share your comments and thoughts below. If you have any questions, please post them to the forum post at the base of the above PAAB page, or follow this link.Thank you and have a great weekend.
PAAB Team
